Warning letters: Investigators refused entry to testing lab; firm cited for distributing unauthorized COVID tests
Regulatory NewsJoanne S. Eglovitch
Audit/FDA InspectionComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy